Search research articles
Contact Us
Filters
Showing results (31-40 of 71) with videos related to
Page
of 8
Sort By:
Breast Cancer Research and Treatment
|
July 29, 1999
Invasion marker PAI-1 remains a strong prognostic factor after long-term follow-up both for primary breast cancer and following first relapse
N Harbeck, C Thomssen, U Berger, et al.
Advances in Clinical Chemistry
|
April 24, 2008
uPA and PAI-1 in breast cancer: review of their clinical utility and current validation in the prospective NNBC-3 trial
K Annecke, M Schmitt, U Euler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2001
Prognostic impact of proteolytic factors (urokinase-type plasminogen activator, plasminogen activator inhibitor 1, and cathepsins B, D, and L) in primary breast cancer reflects effects of adjuvant systemic therapy
N Harbeck, U Alt, U Berger, et al.
Oncogene
|
June 5, 2007
Expression of the RNA-binding protein IMP1 correlates with poor prognosis in ovarian carcinoma
M Köbel, D Weidensdorfer, C Reinke, et al.
Thrombosis and Haemostasis
|
July 1, 1997
Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy
M Schmitt, N Harbeck, C Thomssen, et al.
British Journal of Cancer
|
July 17, 1999
Risk-group discrimination in node-negative breast cancer using invasion and proliferation markers: 6-year median follow-up
N Harbeck, P Dettmar, C Thomssen, et al.
Anticancer Research
|
August 15, 1998
Prognostic impact of tumor biological factors on survival in node-negative breast cancer
N Harbeck, P Dettmar, C Thomssen, et al.
Blut
|
January 1, 1989
Treatment of thrombocytosis in myeloproliferative disorders with interferon alpha-2a
A Tichelli, A Gratwohl, C Berger, et al.
Schweizerische Medizinische Wochenschrift
|
March 23, 1991
[Emergency therapy with granulocyte-macrophage colony-stimulating factor (GM-CSF)]
A Gratwohl, H Dazzi, A Tichelli, et al.
Infection
|
April 29, 1999
Human parvovirus B19-associated disease in bone marrow transplantation
M Schleuning, G Jäger, E Holler, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 71) with videos related to
Sort By:
Page
of 8
Breast Cancer Research and Treatment
|
July 29, 1999
Invasion marker PAI-1 remains a strong prognostic factor after long-term follow-up both for primary breast cancer and following first relapse
N Harbeck, C Thomssen, U Berger, et al.
Advances in Clinical Chemistry
|
April 24, 2008
uPA and PAI-1 in breast cancer: review of their clinical utility and current validation in the prospective NNBC-3 trial
K Annecke, M Schmitt, U Euler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 14, 2001
Prognostic impact of proteolytic factors (urokinase-type plasminogen activator, plasminogen activator inhibitor 1, and cathepsins B, D, and L) in primary breast cancer reflects effects of adjuvant systemic therapy
N Harbeck, U Alt, U Berger, et al.
Oncogene
|
June 5, 2007
Expression of the RNA-binding protein IMP1 correlates with poor prognosis in ovarian carcinoma
M Köbel, D Weidensdorfer, C Reinke, et al.
Thrombosis and Haemostasis
|
July 1, 1997
Clinical impact of the plasminogen activation system in tumor invasion and metastasis: prognostic relevance and target for therapy
M Schmitt, N Harbeck, C Thomssen, et al.
British Journal of Cancer
|
July 17, 1999
Risk-group discrimination in node-negative breast cancer using invasion and proliferation markers: 6-year median follow-up
N Harbeck, P Dettmar, C Thomssen, et al.
Anticancer Research
|
August 15, 1998
Prognostic impact of tumor biological factors on survival in node-negative breast cancer
N Harbeck, P Dettmar, C Thomssen, et al.
Blut
|
January 1, 1989
Treatment of thrombocytosis in myeloproliferative disorders with interferon alpha-2a
A Tichelli, A Gratwohl, C Berger, et al.
Schweizerische Medizinische Wochenschrift
|
March 23, 1991
[Emergency therapy with granulocyte-macrophage colony-stimulating factor (GM-CSF)]
A Gratwohl, H Dazzi, A Tichelli, et al.
Infection
|
April 29, 1999
Human parvovirus B19-associated disease in bone marrow transplantation
M Schleuning, G Jäger, E Holler, et al.
Page
of 8